Lake Street Private Wealth’s Ginkgo Bioworks DNA Stock Holding History

Lake Street Private Wealth’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-766	Closed	-$10.2K	–	275
2024 Q2	$10.2K	Hold	766	–	–	﹤0.01%	320
2024 Q1	$35.5K	Buy	766 +515	+205%	+$26.7K	﹤0.01%	313
2023 Q4	$17K	Hold	251	–	–	﹤0.01%	301
2023 Q3	$17.3K	Hold	251	–	–	﹤0.01%	281
2023 Q2	$18.7K	Hold	251	–	–	﹤0.01%	284
2023 Q1	$13.4K	Hold	251	–	–	﹤0.01%	284
2022 Q4	$16.8K	Buy	251 +1	+0.4%	+$92	﹤0.01%	277
2022 Q3	$31K	Buy	+250	New	+$29.8K	0.01%	271

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Lake Street Private Wealth's DNA Position: Q3 2024 in Review

Lake Street Private Wealth sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 766 shares — an estimated $10.2K sold.

Lake Street Private Wealth first reported a position in DNA in Q3 2022 and held it in 8 quarters. The position peaked at $35.5K in Q1 2024. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

Lake Street Private Wealth reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
Lake Street Private Wealth sold 766 Ginkgo Bioworks shares in Q3 2024, an estimated $10.2K.
Lake Street Private Wealth first reported a position in Ginkgo Bioworks in Q3 2022 and held it in 8 quarters.
Lake Street Private Wealth's Ginkgo Bioworks position peaked at $35.5K in Q1 2024.
159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Lake Street Private Wealth's 13F filing for Q3 2024, filed 22 Oct 2024.